The Cure Cancer Research Grants 2027 support early-career researchers developing innovative projects in paediatric and adolescent cancers or cancer immunotherapy. The round offers funding to help emerging scientists advance promising ideas and build their research careers.
Applications begin with an expression of interest, followed by an invitation-only full proposal. Alongside research funding, Cure Cancer offers mentoring and professional development opportunities connecting emerging researchers with its alumni community.
Eligibility Criteria
- Applicants must have the legal right to work in Australia and conduct the research there.
- Grants must be administered through an NHMRC-approved institution.
- Applicants must meet the seven-year career eligibility window as of July 1, 2027. The earlier applicable PhD completion or clinical-degree date is used; approved career disruptions may extend eligibility.
- Projects must address cancers diagnosed at ages 0–17, cancer immunotherapy, or both.
- Applicants must have received less than AUD $300,000 cumulatively in competitive research funding as lead investigator. Salary-only fellowships and co-investigator awards do not count towards this threshold.
- Chief investigators must commit at least 0.5 FTE to the project.
- Only one expression of interest per chief investigator is permitted.
- Proposed work must not duplicate already funded research.
Funding Details
- Maximum award: AUD $100,000.
- Duration: Up to 12 months.
- Supports eligible direct research costs.
Deadline
- Expression of interest: December 2, 2026.
- Invited full applications: March 31, 2027.
- Funding begins: July 1, 2027.